Published in J Immunol on November 15, 1997
Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun (2001) 3.55
The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J (2000) 2.82
An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity (2012) 2.01
Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection. Infect Immun (2000) 1.53
The two murein lipoproteins of Salmonella enterica serovar Typhimurium contribute to the virulence of the organism. Infect Immun (2004) 1.25
Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Infect Immun (2008) 1.24
Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect Immun (1998) 1.19
Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice. Drug Metab Dispos (2005) 1.17
Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS One (2010) 1.10
Identification of Aeromonas veronii genes required for colonization of the medicinal leech, Hirudo verbana. J Bacteriol (2007) 1.07
Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection. Infect Immun (2005) 1.01
Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Infect Immun (2000) 0.98
Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked decrease in toll-like receptor 2-mediated signaling. Infect Immun (2005) 0.97
Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol (2004) 0.93
Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines. Microb Pathog (2007) 0.90
Deletion of the Braun lipoprotein-encoding gene and altering the function of lipopolysaccharide attenuate the plague bacterium. Infect Immun (2012) 0.87
Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines. Antimicrob Agents Chemother (2001) 0.86
Immunostimulation by the synthetic lipopeptide P3CSK4: TLR4-independent activation of the ERK1/2 signal transduction pathway in macrophages. Immunology (2001) 0.84
Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect Immun (1998) 0.82
Single-cell-based sensors and synchrotron FTIR spectroscopy: a hybrid system towards bacterial detection. Biosens Bioelectron (2007) 0.81
Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis. Mol Med (2007) 0.81
Attenuation of Salmonella enterica Serovar Typhimurium by altering biological functions of murein lipoprotein and lipopolysaccharide. Infect Immun (2005) 0.81
Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex. PLoS One (2013) 0.77
The Cross-Talk between Spirochetal Lipoproteins and Immunity. Front Immunol (2014) 0.76
Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants. Front Cell Infect Microbiol (2016) 0.75
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (1999) 7.75
Localization of cholera toxin in vivo. J Infect Dis (1972) 3.09
In vitro detection of antibody to cholera enterotoxin in cholera patients and laboratory animals. Infect Immun (1970) 2.91
The interferons. Mechanisms of action and clinical applications. JAMA (1991) 2.68
Primary structure of cholera toxin beta-chain: a glycoprotein hormone analog? Science (1977) 2.66
BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro. J Immunol (1978) 2.60
Expression of hydroxamate and phenolate siderophores by Shigella flexneri. J Bacteriol (1983) 2.46
Isolation of skin permeability factors from culture filtrates of Salmonella typhimurium. Infect Immun (1976) 2.13
Novel T-lymphocyte population in combined immunodeficiency with features of graft-versus-host disease. N Engl J Med (1989) 1.99
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology (2001) 1.94
Neutralization of Salmonella toxin-induced elongation of Chinese hamster ovary cells by cholera antitoxin. Infect Immun (1977) 1.90
Vanadate and phosphate ions reduce tension and increase cross-bridge kinetics in chemically skinned heart muscle. Biochim Biophys Acta (1981) 1.74
Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages. J Immunol (1993) 1.73
Covalent structure of the beta chain of cholera enterotoxin. J Biol Chem (1977) 1.64
Radioimmunoassay for the antigenic determinants of cholera toxin and its components. Infect Immun (1977) 1.62
The differentiation of cytotoxic T cells in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent. J Immunol (1979) 1.56
Cloning, expression, and sequence analysis of a cytolytic enterotoxin gene from Aeromonas hydrophila. Can J Microbiol (1993) 1.51
Cholera on the Texas Gulf Coast. JAMA (1982) 1.50
Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation. Cell (1981) 1.49
Antigenic specificity of neutralizing antibody to cholera toxin. Infect Immun (1979) 1.48
Phospholipase A2 activating protein and idiopathic inflammatory bowel disease. Gut (1996) 1.48
Interferon gamma (IFN-gamma) production by gut-associated lymphoid tissue and spleen following oral Salmonella typhimurium challenge. Microb Pathog (1991) 1.44
Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect Immun (1993) 1.36
Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine. Infect Immun (1979) 1.30
Evidence of a role for permeability factors in the pathogenesis of salmonellosis. Am J Clin Nutr (1979) 1.30
Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. Infect Immun (1986) 1.26
The two murein lipoproteins of Salmonella enterica serovar Typhimurium contribute to the virulence of the organism. Infect Immun (2004) 1.25
Tumor necrosis factor-alpha mediates the early pathology in Salmonella infection of the gastrointestinal tract. Microb Pathog (1993) 1.24
Conversion of cholera exo-enterotoxin (choleragen) to natural toxoid (choleragenoid). J Immunol (1971) 1.24
Role of interferon in streptococcal infection in the mouse. Microb Pathog (1986) 1.24
Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect Immun (1995) 1.24
Natural cytotoxic effector cell activity against Shigella flexneri-infected HeLa cells. J Immunol (1986) 1.23
Role of a cytotoxic enterotoxin in Aeromonas-mediated infections: development of transposon and isogenic mutants. Infect Immun (1998) 1.22
Structure, function, and antigenicity of cholera toxin. J Supramol Struct (1979) 1.22
The cytotoxic enterotoxin of Aeromonas hydrophila induces proinflammatory cytokine production and activates arachidonic acid metabolism in macrophages. Infect Immun (2000) 1.21
Ity influences the production of IFN-gamma by murine splenocytes stimulated in vitro with Salmonella typhimurium. J Immunol (1993) 1.19
Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect Immun (1998) 1.19
Molecular characterization of a glucose-inhibited division gene, gidA, that regulates cytotoxic enterotoxin of Aeromonas hydrophila. Infect Immun (2004) 1.18
Quantitation of HeLa cell monolayer invasion by Shigella and Salmonella species. J Clin Microbiol (1985) 1.17
Molecular characterization of an enterotoxin from Salmonella typhimurium. Microb Pathog (1994) 1.15
Shigella flexneri invasion of HeLa cells induces NF-kappa B DNA-binding activity. Infect Immun (1993) 1.14
Cholera toxin-like toxin released by Salmonella species in the presence of mitomycin C. Infect Immun (1980) 1.14
Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J Clin Invest (1996) 1.13
Expression of IL-10 receptors on epithelial cells from the murine small and large intestine. Int Immunol (2000) 1.12
Protection against experimental cholera by oral or parenteral immunization. Infect Immun (1979) 1.11
Hyperproduction, purification, and mechanism of action of the cytotoxic enterotoxin produced by Aeromonas hydrophila. Infect Immun (1997) 1.10
Molecular and biochemical characterization of a heat-labile cytotonic enterotoxin from Aeromonas hydrophila. Microb Pathog (1996) 1.10
Prostaglandin levels in stimulated macrophages are controlled by phospholipase A2-activating protein and by activation of phospholipase C and D. J Biol Chem (2000) 1.09
Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin. J Immunol (1996) 1.09
Double-negative (CD4- CD8-) T cells with an alpha/beta T cell receptor. Non-MHC-restricted cytolytic activity and lymphokine production. J Immunol (1990) 1.08
Type I and type II cyclic AMP-dependent protein kinase as opposite effectors of lymphocyte mitogenesis. Nature (1977) 1.07
Gamma interferon (IFN gamma) and IFN alpha/beta suppress murine myeloid colony formation (CFU-C)N: magnitude of suppression is dependent upon level of colony-stimulating factor (CSF). J Immunol (1982) 1.07
Tumor necrosis factor (TNF alpha) regulates intestinal mucus production during salmonellosis. Cell Immunol (1993) 1.07
In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease. J Immunol (1988) 1.06
Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. Cell Immunol (1996) 1.05
Bacteria-infected fibroblasts have enhanced susceptibility to the cytotoxic action of tumor necrosis factor. J Immunol (1990) 1.05
Direct cytolysis by partially-purified preparations of immune interferon. Int J Cancer (1982) 1.04
Cyclosporin A inhibits the production of gamma interferon (IFN gamma), but does not inhibit production of virus-induced IFN alpha/beta. Cell Immunol (1983) 1.03
Radiolabeled toxin for studying binding of cholera toxin and toxoids to intestinal mucosal receptor sites. Proc Soc Exp Biol Med (1974) 1.02
WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Oncogene (1996) 1.02
Influence of cultural conditions on mitomycin C-mediated bacteriophage induction and release of Salmonella toxin. Infect Immun (1981) 1.01
Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. J Neuropathol Exp Neurol (1996) 1.01
Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection. Infect Immun (2005) 1.01
Rate-limiting steps in the tension development of freeze-glycerinated vascular smooth muscle. J Gen Physiol (1982) 1.00
Thrombin induces IL-6 production in fibroblasts and epithelial cells. Evidence for the involvement of the seven-transmembrane domain (STD) receptor for alpha-thrombin. J Immunol (1995) 0.99
Natural killer cell defects resulting from thermal injury. Cell Immunol (1984) 0.98
Cloning and expression of the Salmonella enterotoxin gene. J Bacteriol (1987) 0.98
Early cell signaling by the cytotoxic enterotoxin of Aeromonas hydrophila in macrophages. Microb Pathog (2002) 0.98
Characterization of the antigenic determinants of cholera toxin subunits. Infect Immun (1979) 0.98
Natural killer cell activation and interferon production by peripheral blood lymphocytes after exposure to bacteria. Infect Immun (1988) 0.98
Oxygen consumption rate in vascular smooth muscle: relation to isometric tension. Biochim Biophys Acta (1973) 0.96
Bacterial invasion of fibroblasts induces interferon production. J Immunol (1987) 0.96
Vanadate ion inhibits actomyosin interaction in chemically skinned vascular smooth muscle. Biochem Biophys Res Commun (1980) 0.96
Defective NK cell activity following thermal injury. Clin Exp Immunol (1986) 0.96
Thymic hypoplasia and T-cell deficiency in ectodermal dysplasia: case report and review of the literature. Clin Immunol Immunopathol (1994) 0.96
Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11. Cancer Chemother Pharmacol (1997) 0.96
Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14. J Immunol (2000) 0.95
Antisera to selected outer membrane proteins of Vibrio cholerae protect against challenge with homologous and heterologous strains of V. cholerae. FEMS Immunol Med Microbiol (1998) 0.95
Amyloid load and neural elements in Alzheimer's disease and nondemented individuals with high amyloid plaque density. Exp Neurol (1996) 0.95
Structural analysis of adult and larval isozymes of sn-glycerol-3-phosphate dehydrogenase of Drosophila melanogaster. J Biol Chem (1982) 0.94
Pathogenesis of experimental salmonellosis: inhibition of protein synthesis by cytotoxin. Infect Immun (1984) 0.94
Human T-cell recognition of Listeria monocytogenes: recognition of listeriolysin O by TcR alpha beta + and TcR gamma delta + T cells. Infect Immun (1995) 0.94